Insituto Catalán de Oncologia (ICO)

Barcelona 08907

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer — Running, not enrolling